Tasly Pharmaceutical Group Co Ltd

Tasly Pharmaceutical Group Co., Ltd. is a Chinese healthcare company that specializes in traditional Chinese medicine and has a strong market presence, with a market capitalization of 24.2 billion CNH and a price-to-earnings ratio of 24.9.

Tasly Pharmaceutical Group Co Ltd has outperformed the industry with a 9.7% share surge, driven by its robust pipeline of 83 projects, including 31 innovative drugs, and a strategic focus on traditional Chinese medicine and biological medicine.

A new wave of market activity has swept through the A-share market, with technology and innovative pharmaceuticals leading the charge, driven by policy support and improving market conditions.